Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences.

Leerink Partners 5th Annual Global Healthcare ConferenceWednesday, February 10, 2016 at 8:50 a.m. ET in New York, NY

RBC Capital Markets’ 2016 Global Healthcare Conference Tuesday, February 23, 2016 at 4:05 p.m. ET in New York, NY

The audio webcast of the presentation will be available live on the “Investors” section of the company’s website located at www.momentapharma.com.  A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available for two weeks following the presentation.

About Momenta Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for oncology and autoimmune indications.

To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.

Sarah Carmody
Momenta Pharmaceuticals
1-617-395-5189
[email protected]

Source: Momenta Pharmaceuticals, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Shanghai Electric Contributes to World-record Biomethanol Bunkering Operation
• AI-powered Martech Firm Tec-Do Announces  Completion of New Financing Round
• Cornelis and NEC Corporation Expand Collaboration to Advance AI and HPC Infrastructure in Japan